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A wide variety of Gram-negative bacterial pathogens
use a ‘type III’ protein secretion system to deliver
bacterial virulence factors into host cells. Recent results
suggest that Gram-positive pathogens may employ
similar methods to deliver virulence factors into host
cells.
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Delivery of virulence factors into host cells to interfere with
and alter host processes is a crucial step in bacterial viru-
lence. Pathogenic bacteria can be broadly divided into
Gram-positive bacteria and Gram-negative bacteria, on the
basis of their cell surface structures. Understanding protein
delivery mechanisms has been pioneered in Gram-negative
bacterial pathogens, with the identification of the so-called
‘type III’ secretion system in 1980 (reviewed in [1,2]). The
type III secretion system delivers bacterial effectors directly
from the cytoplasm of the bacterium into the host cell, thus
crossing the bacterial inner membrane, peptidoglycan and
the outer membrane, and the host plasma membrane.
While the effectors are varied between pathogens, the
greater than 20 type III apparatus components that have
been identified are quite conserved across species. 
A type III secretion system has not been identified
in Gram-positive pathogenic bacteria, nor until recently
had  any analagous system for delivering virulence factors
into host cells been identified in such pathogens. This is
not that surprising, considering the marked difference in
cell-surface structure between Gram-negative and Gram-
positive bacteria — which do not have an outer mem-
brane. New evidence now suggests that a system that is
analogous to the type III system exists in Gram-positive
pathogens; this is based on recently reported findings in
Streptococcus pyogenes, the infectious agent of throat, soft
tissue and systemic infections [3].
Gram-positive secretions
Many Gram-positive pathogens secrete A–B toxins, where
‘A’ is the enzymatically active component, and ‘B’ is the
binding component which aids the internalization of
the toxin into host cells [4]. These toxins, such as C2 toxin
in Clostridium botulinum and diphtheria toxin from
Corynebacterium diphtheriae, have an effect inside the host
cell, in these cases by ADP-ribosylating monomeric G
actin and translation elongation factor 2, respectively. Sim-
ilarly, anthrax toxin ‘protective antigen’ binds cells and
mediates the entry of two other components to the cyto-
plasm via the endosomal pathway [5].
Gram-positive bacteria also secrete proteins that have an
extracellular effect, such as the superantigens and proteases
of S. pyogenes [6]. The question that arises is how secreted
proteins are delivered into host cells, if the proteins are
not A–B toxins but have an obvious requirement to reach
an intracellular compartment. Group A and group C strep-
tococcus have been known to secrete a protein with NAD-
glycohydrolase activity for many years [7,8]. It seems
evident that this protein could play a role in pathogenesis
inside the host cell, but it is not understood how it could
get to this site of action.
Creating a pore
S. pyogenes streptolysin O is a member of a family of pore-
forming cholesterol-dependent cytolysins that includes
Listeria monocytogenes listeriolysin O and Clostridium perfrin-
gens perfringolysin O (reviewed in [9]). This family of
toxins shares a 30–60% similarity in amino acid sequence,
with an invariant region at the carboxy-terminus (ECT-
GLAWEWWR) that is important for cytolytic activity.
The cholesterol-dependent cytolysins are secreted as
47–60 kDa proteins by the general secretory pathway,
with cleavable amino-terminal signal sequences. The
secreted cytolysin monomers bind cholesterol in the host
cell membrane and assemble into a large transmembrane
pore of approximately 30 nm in diameter. While many of
the cholesterol-dependent cytolysins have demonstrated
cytolytic activity, it is thought that they may have a more
subtle function as well [9]. An example of this is that while
an slo mutant, defective in streptolysin O, still attached to
host cells, it lost the ability to manipulate proinflammatory
responses in keratinocytes [10].
Cytolysin-mediated translocation
By a stroke of good fortune, Madden et al. [3] identified
a 52 kDa protein that could be detected in the cytosol
of aCaT keratinocytes — by cross-reaction of anti-
streptolysin O antiserum to the 52 kDa band — only after
infection by a streptolysin O-containing S. pyogenes.
Amino-terminal sequencing of the 52 kDa band identified
it as an S. pyogenes protein that is almost identical to the
mature secreted form of group C streptococcal NAD-gly-
cohydrolase [8]. Comparison of the sequence of the
52 kDa band to the S. pyogenes genome revealed that the
region of identity was preceded by a stretch of 37 amino
acid residues characteristic of a signal sequence. This
S. pyogenes protein was designated SPN, for S. pyogenes
NAD-glycohydrolase. An spn mutant was constructed,
which did not secrete SPN protein into the extracellular
media or translocate SPN into HaCaT cell cytosol. While
no NAD-glycohydrolase activity was detected in unin-
fected cells, high levels were seen in the cytosol of
HaCaT cells infected with wild-type S. pyogenes, in a
manner dependent on the presence of both SPN and
streptolysin O [3]. The authors called this streptolysin
O-dependent delivery of SPN from streptococcus into
host cells ‘cytolysin-mediated translocation’.
In an elegant experiment, it was demonstrated by co-
infecting HaCaT cells with an spn mutant and an slo
mutant that SPN does not simply diffuse into host cells
through the pores created by streptolysin O [3]. A diffusion
process would only require the presence of both strep-
tolysin O and SPN. SPN was not delivered in the co-infec-
tion experiment, and no NAD-glycohydrolase activity was
detected in HaCaT cells, indicating that this is a coordi-
nated process. Madden et al. [3] went on to show that the
SPN activity in the host cell cytosol was not due to endo-
cytosis or streptococcal invasion by using cytochalasin D,
an inhibitor of actin polymerization and bacterial uptake.
From additional experiments, they concluded that translo-
cation is a polarized process in the presence of the
cytolysin, where SPN is directed into the host cell.
Gram-positive versus Gram-negative translocation
This cytolysin-mediated transport is reminiscent of Gram-
negative type III secretion systems. It is important to
note that, while there are similarities between these two
systems, it would be premature to call the cytolysin-
mediated translocation a Gram-positive type III system.
Table 1 shows a comparison of S. pyogenes cytolysin-
mediated translocation to the type III secretion system
of Gram-negative pathogens. While the pore created in
the host cell membrane by cytolysin-mediated transloca-
tion is much larger than that of the type III system, in
both systems translocation is directional. Most of the
effector proteins in both systems are translocated into the
host cell and not to the extracellular environment ([3],
reviewed in [2]).
The greatest similarity in the function of these systems
seems to be delivery of virulence factors into host cells.
However, there are many notable differences. Type III
effectors do not have cleavable amino-terminal signal
sequences (reviewed in [2]). So far, only one protein
has been identified as part of the cytolysin-mediated
translocation system — the cytolysin — while more than
20 proteins of the type III system have been identified,
including proteins of the bacterial cytosol, inner mem-
brane and outer membrane, proteins that form conduits
to the host cell, and those that form a pore in the host
cell membrane. The completion of the S. pyogenes
genome (http://www.genome.ou.edu/strep.html) may
provide clues to the existence of other cytolysin-medi-
ated translocation components. While cytolysins are
secreted by bacteria as water-soluble monomers, which
then oligomerize and insert spontaneously into host cell
membranes (reviewed in [9]), the host cell pore-forming
type III proteins YopB and YopD from Yersinia enterocolitica
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Table 1
Comparison of  type III secretion and S. pyogenes cytolysin-mediated translocation.
Type III secretion Cytolysin-mediated translocation
Function Delivers virulence factors into host cell Delivers a virulence factor into host cell
Apparatus More than 20 proteins: One protein; potentially more?
inner membrane, outer membrane, Cytolysin in host cell membrane
ATPase, channel/conduit forming, General secretory pathway Sec system
host cell pore-forming (6–7 proteins) form a complex that
crosses bacterial cellular membrane.
Size of pore ≈2 nm ≈30 nm
Effectors Not amino-terminal processed Amino-terminal processed
Recognition signal may reside in
amino-terminal amino acids or 5′ mRNA
Requires effector and Yes Yes
pore-former in same bacterium
Intermediates No periplasmic or extracellular Effector secreted via general secretory pathway
intermediates into extracellular space then translocated
Channel Continuous Not continuous?
Contact-dependent Usually Translocation of SPN always requires adherence
Directional Usually Usually
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are themselves substrates of the type III secretion system
(reviewed in [2]).
The type III secretion system is thought to mediate one-
step translocation of effectors across bacterial and host cell
membranes in a continuous process [11]. On the surface, it
appears that, since SPN has a cleavable amino-terminal
signal sequence, it is secreted into the extracellular milieu
by the general secretory pathway before it is translocated
via streptolysin O [3]. However, a strong argument can be
made that cytolysin-mediated translocation is a continuous
process. If extracellular SPN is translocated through the
streptolysin O pore, a mixed infection where one bac-
terium provides SPN and a separate bacterium supplies
streptolysin O would yield SPN activity in the cytosol of
host cells. As mentioned above, co-infection did not
rescue translocation [3]. Similarly, in Yersinia enterocolitica
it has been shown that effectors must be in the same bac-
terium as the one producing the pore-forming YopB and
YopD in order to be delivered into host cells [12].
The proof is still to come
While Madden et al. [3] favour a model in which SPN is
first secreted and then translocated via streptolysin O,
they mention — and their data better support — a model
for cytolysin-mediated translocation in which the effectors
are translocated via a protected channel formed between
the bacterium and the streptolysin O pore in the host cell
(Figure 1). A needle-like complex has been visualized in
many type III secretion systems, including Salmonella spp,
Shigella spp and enteropathogenic Escherichia coli, and data
suggest that this complex serves as a conduit for protein
delivery (reviewed in [2]). The presence or absence of a
protected protein channel in cytolysin-mediated transloca-
tion needs to be investigated.
The new work reported by Madden et al. [3] is an exciting
initial step towards understanding the delivery of virulence
factors from Gram-positive bacteria into host cells. It
remains to be shown if multiple proteins are involved
in the cytolysin-mediated translocation process, as either
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A model of cytolysin-mediated transport compared to Gram-negative
pathogens type III secretion system. In cytolysin-mediated translocation,
the effectors are secreted via the general secretory pathway into an as
yet unidentified channel, which delivers the effectors to the large pore
formed by the cytolysin for translocation into the host cell cytosol. For
type III secretion, the effectors are delivered through a continuous
machinery through both bacterial membranes and host cell membranes.
In enteropathogenic Escherichia coli, the secretion complex in the
bacterium is formed by the Escs, the channel is formed by EspA, and the
pore in the host cell membrane by EspB and EspD (reviewed in [1,2]).
effectors or components of the translocation system. Con-
siderable work is needed to determine if the effectors are
translocated through a continuous channel. As additional
studies progress, it will be interesting to determine how
widespread this mechanism is in Gram-positive pathogens.
Many lessons have been learned from the years of study of
the Gram-negative type III secretion system, the most
important being the complexity and intricacy of the viru-
lence delivery systems.
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